Blue Earth Diagnostics

Blue Earth Diagnostics company information, Employees & Contact Information

Updated May 2026

Quick answer

Blue Earth Diagnostics is a Pharmaceutical Manufacturing company and founded in 2014. It has approximately 103 employees on record. Contact data was last refreshed in May 2026. Find Blue Earth Diagnostics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., is a growing international molecular imaging company focused on delivering innovative, well-differentiated diagnostic solutions that inform patient care. Formed in 2014, the Company’s success is driven by its management expertise and supported by a demonstrated track record of rapid development and commercialization of positron emission tomography (PET) radiopharmaceuticals. With a clinical focus in cancer, Blue Earth Diagnostics’ expanding pipeline encompasses a variety of disease states, including prostate cancer and neuro-oncology. Blue Earth Diagnostics is committed to the timely development and commercialization of precision radiopharmaceuticals for potential use in imaging and therapy.

Company Details

Employees
103
Founded
2014
Address
Magdalen Centre, The Oxford Science Park,united States
Phone
4401865784186
Email
co****@****hDx.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Oxford
Looking for a particular Blue Earth Diagnostics employee's phone or email?

Blue Earth Diagnostics Questions

News

Blue Earth Diagnostics, a Bracco Company, Applauds New CMS Rule to Support Patient Access Through Improved Payment for Specialized Diagnostic Radiopharmaceuticals - Business Wire

Blue Earth Diagnostics, a Bracco Company, Applauds New CMS Rule to Support Patient Access Through Improved Payment for Specialized Diagnostic Radiopharmaceuticals Business Wire

Blue Earth Diagnostics Highlights Presentations on POSLUMA (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting - Imaging Technology News

Blue Earth Diagnostics Highlights Presentations on POSLUMA (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting Imaging Technology News

Philochem and Blue Earth Diagnostics Announce First Three - GlobeNewswire

Philochem and Blue Earth Diagnostics Announce First Three GlobeNewswire

Bracco to acquire Blue Earth Diagnostics - AuntMinnie

Bracco to acquire Blue Earth Diagnostics AuntMinnie

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer to Lead Company’s Next Phase of Business Growth - Business Wire

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer to Lead Company’s Next Phase of Business Growth Business Wire

Blue Earth Diagnostics sold to Bracco Imaging in $450M deal - Fierce Biotech

Blue Earth Diagnostics sold to Bracco Imaging in $450M deal Fierce Biotech

GE Healthcare, Blue Earth Diagnostics ink UK manufacturing deal - Drug Delivery Business

GE Healthcare, Blue Earth Diagnostics ink UK manufacturing deal Drug Delivery Business

Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases - Imaging Technology News

Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases Imaging Technology News

Blue Earth Diagnostics, a Bracco Company, Lauds CMS Proposal to Support Patient Access Through Improved Payment for Specialized Diagnostic Radiopharmaceuticals - Business Wire

Blue Earth Diagnostics, a Bracco Company, Lauds CMS Proposal to Support Patient Access Through Improved Payment for Specialized Diagnostic Radiopharmaceuticals Business Wire

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer - Imaging Technology News

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer Imaging Technology News

Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA - Business Wire

Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA Business Wire

Axumin PET Injection Now Commercially Available in United States - Imaging Technology News

Axumin PET Injection Now Commercially Available in United States Imaging Technology News

Blue Earth Diagnostics Announces CMS Transitional Pass-Through Payment Reimbursement Code for POSLUMA® (Flotufolastat F 18) Injection, Effective October 1, 2023 - Business Wire

Blue Earth Diagnostics Announces CMS Transitional Pass-Through Payment Reimbursement Code for POSLUMA® (Flotufolastat F 18) Injection, Effective October 1, 2023 Business Wire

Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer - Imaging Technology News

Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer Imaging Technology News

Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating Diagnostic Performance of POSLUMA® (Flotufolastat F 18) and Clinical Trial Enrollment in African American Men with Prostate Cancer - Business Wire

Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating Diagnostic Performance of POSLUMA® (Flotufolastat F 18) and Clinical Trial Enrollment in African American Men with Prostate Cancer Business Wire

Axumin (Fluciclovine F-18) PET Tracer Effective in Detecting Recurrent Prostate Cancer - Imaging Technology News

Axumin (Fluciclovine F-18) PET Tracer Effective in Detecting Recurrent Prostate Cancer Imaging Technology News

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer - Business Wire

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer Business Wire

(Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer - Business Wire

(Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer Business Wire

Blue Earth Diagnostics and PETNET Solutions Inc, A Siemens Healthineers Company, Announce U.S. Commercial Availability of POSLUMA® (Flotufolastat F 18) Injection for PET Imaging of Prostate Cancer - Business Wire

Blue Earth Diagnostics and PETNET Solutions Inc, A Siemens Healthineers Company, Announce U.S. Commercial Availability of POSLUMA® (Flotufolastat F 18) Injection for PET Imaging of Prostate Cancer Business Wire

Helen Barker joins Blue Earth Diagnostics - PharmaTimes

Helen Barker joins Blue Earth Diagnostics PharmaTimes

Top Blue Earth Diagnostics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant